Rachel Bandli’s practice focuses on complex commercial and intellectual property litigation.  She has experience representing pharmaceutical companies in Hatch-Waxman patent infringement actions, as well as matters involving biosimilars.  She has also worked on multiple inter partes review (IPR) proceedings involving pharmaceutical products and medical devices.